Nova Biomedical

Company Overview

Nova Biomedical is a privately held in vitro diagnostics (IVD) company that operates globally through sales and service operations in 100 countries. The company specializes in critical care testing, point-of-care diagnostics, and cell culture analysis. Its product portfolio includes hospital-grade blood gas and critical care analyzers, handheld glucose and ketone meters, and automated cell culture chemistry systems. Designed for fast turnaround and reliable results, its solutions serve ICU, emergency, surgical, respiratory, and lab settings to improve clinical outcomes while managing healthcare costs. In the patient monitoring and diagnostic domain, Nova offers the Stat Profile family of analyzers, which are designed for hospitals and point-of-care settings.

Company's Business Segments

• Blood Testing Analyzers : This segment provides critically ill and hospitalized patients with most expensive blood analyzing tests in a shorter time period.